How Have the Numbers Shaped Up for Healthequity Stock Forecast, Price & News (NASDAQ:HQY)

0
181

Earnings results for Healthequity Stock Forecast, Price & News (NASDAQ:HQY)

HealthEquity, Inc. is expected* to report earnings on 09/08/2020 after market close. The report will be for the fiscal Quarter ending Jul 2020. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.15. The reported EPS for the same quarter last year was $0.36.

Healthequity last posted its earnings results on June 2nd, 2020. The reported $0.43 EPS for the quarter, missing the consensus estimate of $0.44 by $0.01. The business earned $190 million during the quarter, compared to analysts’ expectations of $193.32 million. Its quarterly revenue was up 118.4% compared to the same quarter last year. Healthequity has generated $1.38 earnings per share over the last year and currently has a price-to-earnings ratio of 1,949.0. Healthequity has confirmed that its next quarterly earnings report will be published on Tuesday, September 8th, 2020.

Analyst Opinion on Healthequity Stock Forecast, Price & News (NASDAQ:HQY)

11 Wall Street analysts have issued ratings and price targets for Healthequity in the last 12 months. Their average twelve-month price target is $63.55, predicting that the stock has a possible upside of 8.68%. The high price target for HQY is $87.00 and the low price target for HQY is $47.00. There are currently 3 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of “Buy.”

Healthequity has received a consensus rating of Buy. The company’s average rating score is 2.82, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $63.55, Healthequity has a forecasted upside of 8.7% from its current price of $58.47. Healthequity has received no research coverage in the past 90 days.

Dividend Strength: Healthequity Stock Forecast, Price & News (NASDAQ:HQY)

Healthequity does not currently pay a dividend. Healthequity does not have a long track record of dividend growth.

Insiders buying/selling: Healthequity Stock Forecast, Price & News (NASDAQ:HQY)

In the past three months, Healthequity insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $975,000.00 in company stock. Only 3.70% of the stock of Healthequity is held by insiders. 98.01% of the stock of Healthequity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Healthequity Stock Forecast, Price & News (NASDAQ:HQY

Earnings for Healthequity are expected to grow by 1.01% in the coming year, from $0.99 to $1.00 per share. The P/E ratio of Healthequity is 1,949.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.60. The P/E ratio of Healthequity is 1,949.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.48. Healthequity has a PEG Ratio of 4.09. PEG Ratios above 1 indicate that a company could be overvalued. Healthequity has a P/B Ratio of 4.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here